These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 38173208)
1. Identification of Novel EGFR Inhibitors for the Targeted Therapy of Colorectal Cancer Using Pharmacophore Modelling, Docking, Molecular Dynamic Simulation and Biological Activity Prediction. Krishnan K A; Valavi SG; Joy A Anticancer Agents Med Chem; 2024; 24(4):263-279. PubMed ID: 38173208 [TBL] [Abstract][Full Text] [Related]
2. Ligand- and structure-based in silico studies to identify kinesin spindle protein (KSP) inhibitors as potential anticancer agents. Balakumar C; Ramesh M; Tham CL; Khathi SP; Kozielski F; Srinivasulu C; Hampannavar GA; Sayyad N; Soliman ME; Karpoormath R J Biomol Struct Dyn; 2018 Nov; 36(14):3687-3704. PubMed ID: 29064326 [TBL] [Abstract][Full Text] [Related]
3. Targeting natural compounds against HER2 kinase domain as potential anticancer drugs applying pharmacophore based molecular modelling approaches. Rampogu S; Son M; Baek A; Park C; Rana RM; Zeb A; Parameswaran S; Lee KW Comput Biol Chem; 2018 Jun; 74():327-338. PubMed ID: 29702367 [TBL] [Abstract][Full Text] [Related]
7. In silico design, synthesis and activity of potential drug-like chrysin scaffold-derived selective EGFR inhibitors as anticancer agents. Debnath S; Kanakaraju M; Islam M; Yeeravalli R; Sen D; Das A Comput Biol Chem; 2019 Dec; 83():107156. PubMed ID: 31710991 [TBL] [Abstract][Full Text] [Related]
8. Ligand-Based Pharmacophore Modeling, Molecular Docking, and Molecular Dynamic Studies of Dual Tyrosine Kinase Inhibitor of EGFR and VEGFR2. Sangande F; Julianti E; Tjahjono DH Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33096664 [TBL] [Abstract][Full Text] [Related]
9. Pharmacophore based virtual screening for identification of effective inhibitors to combat HPV 16 E6 driven cervical cancer. Mohan A; Krishnamoorthy S; Sabanayagam R; Schwenk G; Feng E; Ji HF; Muthusami S Eur J Pharmacol; 2023 Oct; 957():175961. PubMed ID: 37549730 [TBL] [Abstract][Full Text] [Related]
10. QSAR modeling, pharmacophore-based virtual screening, and ensemble docking insights into predicting potential epigallocatechin gallate (EGCG) analogs against epidermal growth factor receptor. Bommu UD; Konidala KK; Pabbaraju N; Yeguvapalli S J Recept Signal Transduct Res; 2019 Feb; 39(1):18-27. PubMed ID: 31223050 [TBL] [Abstract][Full Text] [Related]
11. Pharmacophore, 3D-QSAR Models and Dynamic Simulation of 1,4-Benzothiazines for Colorectal Cancer Treatment. Rai A; Raj V; Aboumanei MH; Singh AK; Keshari AK; Verma SP; Saha S Comb Chem High Throughput Screen; 2017; 20(8):658-674. PubMed ID: 28486913 [TBL] [Abstract][Full Text] [Related]
12. Discovery of the allosteric inhibitor from actinomyces metabolites to target EGFR Saini R; Kumari S; Bhatnagar A; Singh A; Mishra A Sci Rep; 2023 Jun; 13(1):8885. PubMed ID: 37264083 [TBL] [Abstract][Full Text] [Related]
13. Identification of potential PKC inhibitors through pharmacophore designing, 3D-QSAR and molecular dynamics simulations targeting Alzheimer's disease. Iqbal S; Anantha Krishnan D; Gunasekaran K J Biomol Struct Dyn; 2018 Nov; 36(15):4029-4044. PubMed ID: 29182053 [TBL] [Abstract][Full Text] [Related]
14. Computational Evaluation and In Vitro Validation of New Epidermal Growth Factor Receptor Inhibitors. Gómez-Ganau S; Castillo J; Cervantes A; de Julián-Ortiz JV; Gozalbes R Curr Top Med Chem; 2020; 20(18):1628-1639. PubMed ID: 32493189 [TBL] [Abstract][Full Text] [Related]
16. Pharmacophore modeling and virtual screening in search of novel Bruton's tyrosine kinase inhibitors. Sharma A; Thelma BK J Mol Model; 2019 Jun; 25(7):179. PubMed ID: 31172362 [TBL] [Abstract][Full Text] [Related]
17. An In Silico Investigation of Potential EGFR Inhibitors for the Clinical Treatment of Colorectal Cancer. Majhi M; Ali MA; Limaye A; Sinha K; Bairagi P; Chouksey M; Shukla R; Kanwar N; Hussain T; Nayarisseri A; Singh SK Curr Top Med Chem; 2018; 18(27):2355-2366. PubMed ID: 30499396 [TBL] [Abstract][Full Text] [Related]
18. Molecular dynamics guided insight, binding free energy calculations and pharmacophore-based virtual screening for the identification of potential VEGFR2 inhibitors. Rathi E; Kumar A; Kini SG J Recept Signal Transduct Res; 2019; 39(5-6):415-433. PubMed ID: 31755336 [TBL] [Abstract][Full Text] [Related]
19. Pharmacophore and Docking Guided Virtual Screening Study for Discovery of Type I Inhibitors of VEGFR-2 Kinase. Bhojwani HR; Joshi UJ Curr Comput Aided Drug Des; 2017; 13(3):186-207. PubMed ID: 27981900 [TBL] [Abstract][Full Text] [Related]